Avantor, Inc. (NYSE:AVTR – Get Free Report) CAO Steven W. Eck sold 4,907 shares of the firm’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Avantor Stock Performance
Avantor stock opened at $16.71 on Friday. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $11.37 billion, a PE ratio of 16.06, a P/E/G ratio of 1.55 and a beta of 1.28. The firm has a fifty day simple moving average of $20.51 and a two-hundred day simple moving average of $22.67. Avantor, Inc. has a twelve month low of $16.41 and a twelve month high of $28.00.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the prior year, the firm earned $0.22 earnings per share. Research analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.
Hedge Funds Weigh In On Avantor
Wall Street Analyst Weigh In
Several brokerages have commented on AVTR. Barclays cut their price target on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a report on Monday, February 10th. UBS Group reaffirmed a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Raymond James reaffirmed an “outperform” rating and set a $24.00 price objective (down from $26.00) on shares of Avantor in a report on Monday, February 10th. Royal Bank of Canada dropped their price objective on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a report on Monday, February 10th. Finally, Wells Fargo & Company dropped their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and an average target price of $25.92.
Read Our Latest Stock Analysis on Avantor
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.